EXJADE 125 mg
The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.
- Active substance
- Deferasirox
- Strength
- 125 mg
- Form
- tablet for suspension
- ATC code
- V03AC03
- Registered in
- Canada · Novartis Pharmaceuticals Canada Inc
- Prescription
- Prescription only
- DIN
- 02287420
Source: Drug Product Database · 2026-09-30
Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.
Listed in other countries
United States 11 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| Deferasirox | 125 mg · Tablet, for Suspension | Prescription only | Teva Pharmaceuticals, Inc. (+9) | 0480-7011 |
| Exjade | 125 mg · Tablet, for Suspension | Prescription only | Novartis Pharmaceuticals Corporation | 0078-0468 |
Source: NDC Directory (US Food and Drug Administration) · 2026-09-13 · Source: US Food and Drug Administration, NDC Directory.
Spain 1 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| EXJADE | 125 mg · comprimido dispersable | Prescription only | Novartis Europharm Limited | 06356001 |
Source: CIMA — Centro de Información online de Medicamentos (Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)) · 2026-09-30 · Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA.
Same active substance, but no match for this strength and form
- Bulgaria: 8 products · Every strength and form
- European Union: 3 products · Every strength and form
- Netherlands: 69 products · Every strength and form
- Switzerland: 19 products · Every strength and form